Thudium, Christian S; Nielsen, Signe Holm; Sardar, Samra; Mobasheri, Ali; van Spil, Willem Evert; Lories, Rik; 5882; Henriksen, Kim; Bay-Jensen, Anne-Christine; Karsdal, Morten A;
Osteoarthritis, rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis, all have one clear common denominator; an altered turnover of bone. However, this may be more complex than a simple change in bone matrix and mineral turnover. While these diseases share a common tissue axis, their manifestations in the area of pathology are high...
Razok, Almurtada Malik, Rubab Cackamvalli, Priyanka Zahid, Muhammad
Published in
Annals of Medicine and Surgery
• Retroperitoneal fibrosis can present in a variety of clinical pictures. • IgG4 related disease can present with isolated retroperitoneal fibrosis. • It is diagnosed based on clinical, radiological and pathological criteria. • Treatment with corticosteroids can lead to clinical and radiological remission.
Grainger, Rebecca Machado, Pedro M. Robinson, Philip C.
Published in
Best Practice & Research. Clinical Rheumatology
There is concern that people with rheumatic disease, often treated with immunosuppressive or immunomodulatory medication, may be at an increased risk of poor outcomes of novel coronavirus disease-2019 (COVID-19). However, hyperinflammation is a major cause of morbidity and mortality in COVID-19 and treatment with glucocorticoids has been shown to i...
Hyrich, Kimme L. Machado, Pedro M.
Published in
Nature Reviews Rheumatology
Patients with rheumatoid arthritis, systemic lupus erythematosus or psoriasis, when analysed as a combined group, might have a slightly increased risk of death from COVID-19 compared to those without these diseases, although the role of disease activity and treatment in this risk estimation was not taken into account2. Treatment with cytokine inhib...
Liu, Qian Zaba, Lisa C. Satpathy, Ansuman T. Longmire, Michelle Zhang, Wen Li, Kun Granja, Jeffrey Guo, Chuang Lin, Jun Li, Rui
...
Published in
Nature Communications
A Correction to this paper has been published: https://doi.org/10.1038/s41467-020-20411-w
Rahmati, Sara O’Rielly, Darren D. Li, Quan Codner, Dianne Dohey, Amanda Jenkins, Kari Jurisica, Igor Gladman, Dafna D. Chandran, Vinod Rahman, Proton
...
Published in
Scientific Reports
Biological therapies have dramatically improved the therapeutic landscape of psoriatic arthritis (PsA); however, 40–50% of patients are primary non-responders with response rates declining significantly with each successive biological therapy. Therefore, there is a pressing need to develop a coherent strategy for effective initial and subsequent se...
Deodhar, Atul; Mease, Philip; Rahman, Proton; Navarro-Compan, Victoria; Marzo-Ortega, Helena; Hunter, Theresa; Sandoval, David; Kronbergs, Andris; Leon, Luis; Shan, Mingyang;
...
INTRODUCTION: Ixekizumab, an interleukin-17A antibody, has shown efficacy in non-radiographic axial spondyloarthritis (nr-axSpA). The objectives of this analysis were (a) to measure improvement in ixekizumab-treated patients in Assessment of Spondyloarthritis International Society (ASAS) response domains and other patient-reported outcomes (PROs) a...
Tesch, Sebastian Abdirama, Dimas Grießbach, Anna-Sophie Brand, Hannah Antonia Goerlich, Nina Humrich, Jens Y. Bacher, Petra Hiepe, Falk Riemekasten, Gabriela Enghard, Philipp
...
Published in
Scientific Reports
In the search for anti-renal autoreactivity in human lupus nephritis, we stimulated blood-derived CD4+ T cells from patients with systemic lupus erythematosus with various kidney lysates. Although only minor responses were detectable, these experiments led to the development of a search algorithm that combined autoantibody association with human lu...
Kaaij, Merlijn H. Helder, Boy van Mens, Leonieke J. J. van de Sande, Marleen G. H. Baeten, Dominique L. P. Tas, Sander W.
Published in
Scientific Reports
Spondyloarthritis (SpA) is characterized by inflammation and new bone formation. The exact pathophysiology underlying these processes remains elusive. We propose that the extensive neoangiogenesis in SpA could play a role both in sustaining/enhancing inflammation and in new bone formation. While ample data is available on effects of anti-TNF on ang...
Taubmann, Jule Krishnacoumar, Brenda Böhm, Christina Faas, Maria Müller, Dorothea I. H. Adam, Susanne Stoll, Cornelia Böttcher, Martin Mougiakakos, Dimitrios Sonnewald, Uwe
...
Published in
Scientific Reports
Osteoclasts are specialised bone resorbing cells that control both physiological and pathological bone turnover. Functional changes in the differentiation and activity of osteoclasts are accompanied by active metabolic reprogramming. However, the biological significance and the in vivo relevance of these events has remained unclear. Here we show th...